Title : Identification of soluble candidate biomarkers of therapeutic response to sunitinib in medullary thyroid carcinoma in preclinical models.

Pub. Date : 2011 Apr 1

PMID : 21325074






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sunitinib, a potent inhibitor of RET, VEGF receptor (VEGFR)-1, VEGFR-2, VEGFR-3, and platelet-derived growth factor receptor (PDGFR)alpha/beta, has been reported as clinically effective in some patients with advanced MTC. Sunitinib ret proto-oncogene Homo sapiens
2 EXPERIMENTAL DESIGN: Both in vitro and in vivo assays, using the human TT RET(C634W) MTC cell line, were done to assess the activity of sunitinib. Sunitinib ret proto-oncogene Homo sapiens
3 RESULTS: Sunitinib displayed antiproliferative and antiangiogenic activities and inhibited RET autophosphorylation and activation of downstream signaling pathways. Sunitinib ret proto-oncogene Homo sapiens